QUIDELORTHO CORP Finance Lease, Principal Payments
QUIDELORTHO CORP (QDEL) reported Finance Lease, Principal Payments of $1.60 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-07
- QUIDELORTHO CORP finance lease, principal payments for the quarter ending 2026-06-28 was $0.00.
- QUIDELORTHO CORP finance lease, principal payments for the quarter ending 2026-03-29 was $1.60M.
- QUIDELORTHO CORP finance lease, principal payments for the quarter ending 2025-06-29 was $0.00.
- QUIDELORTHO CORP finance lease, principal payments for the quarter ending 2025-03-30 was $0.00.
- QUIDELORTHO CORP finance lease, principal payments for fiscal 2024 was $143.00M, a 37.28% decline from fiscal 2023.
- QUIDELORTHO CORP finance lease, principal payments for fiscal 2023 was $228.00M, a 90.45% decline from fiscal 2023.
- QUIDELORTHO CORP finance lease, principal payments for fiscal 2023 was $2.39B, a 796000.00% increase from fiscal 2022.
- QUIDELORTHO CORP finance lease, principal payments for fiscal 2022 was $300.00K, a 40.00% decline from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.60M 10-Q · filed 2026-08-07 | ||
| 2026-03-29 | $1.60M 10-Q · filed 2026-05-06 | |||
| 2025-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | ||
| 2025-03-30 | $0.00 10-Q · filed 2026-05-06 | |||
| 2024-12-29 | $143.00M 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $52.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $104.20M derived: sum of 2 quarters · filed 2025-02-27 | $176.10M derived: sum of 3 quarters · filed 2025-02-27 | $228.00M 10-K · filed 2025-02-27 |
| 2023-10-01 | $51.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $123.80M derived: sum of 2 quarters · filed 2023-11-02 | $175.70M 10-Q · filed 2023-11-02 | $227.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $71.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $123.80M 10-Q · filed 2023-08-09 | $176.00M derived: sum of 3 quarters · filed 2025-02-27 | $227.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $51.90M 10-Q · filed 2023-05-04 | $104.10M derived: sum of 2 quarters · filed 2025-02-27 | $155.80M derived: sum of 3 quarters · filed 2025-02-27 | $2.44B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $52.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $103.90M derived: sum of 2 quarters · filed 2025-02-27 | $2.39B derived: sum of 3 quarters · filed 2025-02-27 | $2.39B 10-K · filed 2025-02-27 |
| 2022-10-02 | $51.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.34B derived: sum of 2 quarters · filed 2023-11-02 | $2.34B 10-Q · filed 2023-11-02 | $2.34B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $2.28B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.28B 10-Q · filed 2023-08-09 | $2.28B derived: sum of 3 quarters · filed 2024-08-01 | $2.28B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $100.00K 10-Q · filed 2023-05-04 | $200.00K derived: sum of 2 quarters · filed 2024-08-01 | $100.00K derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $100.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | $300.00K 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $200.00K 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $300.00K 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $500.00K 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |